Search

This Viewpoint discusses a recent federal court decision that invaliated the Food and Drug Administration's (FDA) approval of mifepristone, a drug used to end pregnancies and manage miscarriage when used with misoprostol, and how that decision challenges the legitimacy and independence of the FDA. [ABSTRACT FROM AUTHOR]

This Viewpoint examines the recent decision by a federal district court that undercuts the Affordable Care Act's mandate for cost-free coverage of preventive services, including contraception, some vaccinations, many screenings, and preexposure prophylaxis for HIV, among others. [ABSTRACT FROM AUTHOR]

In this Viewpoint, Otis Brawley and colleagues review evidence of racial disparities in breast, prostate, and colorectal cancer survival, highlight regional programs that reduced the disparities, and call upon policy makers to institute mandates to equalize quality and access to cancer treatment nationwide. [ABSTRACT FROM AUTHOR]